Andreas Ramming
Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)Universitätsklinikum Erlangen(DE)IU International University of Applied Sciences(DE)Bayer (Germany)(DE)
Publications by Year
Research Areas
Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, IL-33, ST2, and ILC Pathways, Peptidase Inhibition and Analysis, Rheumatoid Arthritis Research and Therapies
Most-Cited Works
- → Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis(2018)707 cited
- → Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis(2017)335 cited
- → Evidence of innate lymphoid cell redundancy in humans(2016)304 cited
- → Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells(2017)285 cited
- → IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin–directed vascular barrier disruption(2019)241 cited
- → SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases(2021)195 cited